Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature

doi:10.5409/wjcp.v10.i4.48

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3837)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

234

WORD

169

HTML

1674

Tables (1-2)

284

Sum=2361

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

238

Download

365

Sum=603

Publishing Process of This Article

Item

Count

Browse

309

Download

564

Sum=873

Jul 9, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

World J Clin Pediatr. Jul 9, 2021; 10(4): 48-52
Published online Jul 9, 2021. doi: 10.5409/wjcp.v10.i4.48

Table 2 Current Indications for prescribing omalizumab

Ref.	Age	Previous treatment
NICE[4]	> 6 yr	Optimised standard treatment with documented compliance
NICE[4]	> 6 yr	Continuous or 4 or more courses of oral steroids in the previous year
NICE[5]	> 12 yr	Poor response to standard treatment with H1-antihistamines and leukotriene receptor antagonists
NICE[5]	> 12 yr	Objective severity score (weekly urticaria activity score) > 28

Citation: Doherty S, Mulholland M, Shields M, McCrossan P. Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature . World J Clin Pediatr 2021; 10(4): 48-52
URL: https://www.wjgnet.com/2219-2808/full/v10/i4/48.htm
DOI: https://dx.doi.org/10.5409/wjcp.v10.i4.48